MAIA Biotechnology, Inc.
MAIA
Positions held
Your positionsMAIA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $71.00M | Enterprise value | $42.35M | Trailing P/E | — | Forward P/E | 1.04 |
| PEG | — | Price / book | 3.38 | Beta | 0.28 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -2.2% | ROA | -92.1% | Debt / equity | — |
| Current ratio | 4.51 | Free cash flow | -$13.79M | Analyst recommendation | none | Mean target | $12.00 |
| 52w high | $3.19 | 52w low | $0.87 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$7.9M | -$6.4M | -$3.6M | -$8.9M | -$5.3M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$8.1M | -$6.7M | -$4.0M | -$9.4M | -$5.2M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$22.4M | -$23.3M | -$19.8M | -$15.8M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$23.9M | -$16.9M | -$20.0M | -$15.9M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
2026-09-23 · MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
2026-09-22 · MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer
2026-09-16 · MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
2026-09-15 · MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
2026-08-17 · Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
Price (daily)
Full chart · RSI · MACD · patterns